4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderRecruitingPhase 1 / Phase 22026-09-22NCT07653685
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal CancerDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasmRecruitingPhase 1 / Phase 22026-09-15NCT07367516
A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionAdvanced Lung CancerRecruitingPhase 1 / Phase 22026-09-08NCT07367529
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsAdvanced Solid TumorsNot yet recruitingPhase 22026-07-31NCT07738679